FDA NDC Directory · JSON-LD · Markdown

Kisunla

NDC 0002-9401 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedonanemab-azbt
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA761248
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsDONANEMAB (17.5 mg/mL)
Marketing started20240702
Package count1

External sources

Source: openFDA. Public-domain (CC0).